A detailed history of Daiwa Securities Group Inc. transactions in Incyte Corp stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 20,649 shares of INCY stock, worth $1.61 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,649
Previous 21,709 4.88%
Holding current value
$1.61 Million
Previous $1.32 Million 3.72%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$57.33 - $68.61 $60,769 - $72,726
-1,060 Reduced 4.88%
20,649 $1.37 Million
Q2 2024

Aug 07, 2024

SELL
$51.18 - $63.75 $575,672 - $717,060
-11,248 Reduced 34.13%
21,709 $1.32 Million
Q1 2024

May 02, 2024

BUY
$56.55 - $66.59 $559,449 - $658,774
9,893 Added 42.89%
32,957 $1.88 Million
Q4 2023

Jan 31, 2024

BUY
$52.16 - $64.19 $135,563 - $166,829
2,599 Added 12.7%
23,064 $1.45 Million
Q3 2023

Nov 01, 2023

BUY
$57.77 - $65.93 $37,666 - $42,986
652 Added 3.29%
20,465 $1.18 Million
Q2 2023

Jul 31, 2023

SELL
$60.95 - $75.51 $38,825 - $48,099
-637 Reduced 3.11%
19,813 $1.23 Million
Q1 2023

May 02, 2023

BUY
$70.23 - $86.01 $90,807 - $111,210
1,293 Added 6.75%
20,450 $1.48 Million
Q4 2022

Feb 06, 2023

BUY
$67.18 - $84.11 $99,023 - $123,978
1,474 Added 8.34%
19,157 $1.54 Million
Q3 2022

Nov 02, 2022

BUY
$66.18 - $82.86 $9,132 - $11,434
138 Added 0.79%
17,683 $1.18 Million
Q2 2022

Aug 09, 2022

BUY
$66.18 - $83.18 $61,084 - $76,775
923 Added 5.55%
17,545 $1.33 Million
Q1 2022

Apr 29, 2022

BUY
$66.02 - $79.71 $304,616 - $367,781
4,614 Added 38.42%
16,622 $1.32 Million
Q4 2021

Feb 03, 2022

SELL
$63.34 - $74.11 $327,721 - $383,445
-5,174 Reduced 30.11%
12,008 $881,000
Q3 2021

Nov 05, 2021

BUY
$68.67 - $84.02 $124,842 - $152,748
1,818 Added 11.83%
17,182 $1.18 Million
Q2 2021

Aug 06, 2021

BUY
$79.87 - $87.53 $57,985 - $63,546
726 Added 4.96%
15,364 $1.29 Million
Q1 2021

May 03, 2021

BUY
$76.02 - $100.5 $117,222 - $154,971
1,542 Added 11.77%
14,638 $1.19 Million
Q4 2020

Feb 04, 2021

BUY
$80.74 - $97.7 $46,667 - $56,470
578 Added 4.62%
13,096 $1.14 Million
Q3 2020

Nov 02, 2020

BUY
$85.07 - $109.69 $234,112 - $301,866
2,752 Added 28.18%
12,518 $1.12 Million
Q1 2020

May 14, 2020

BUY
$63.18 - $85.97 $43,783 - $59,577
693 Added 7.64%
9,766 $715,000
Q4 2019

Jan 31, 2020

SELL
$73.04 - $95.72 $11,248 - $14,740
-154 Reduced 1.67%
9,073 $792,000
Q3 2019

Nov 04, 2019

BUY
$72.82 - $86.52 $38,667 - $45,942
531 Added 6.11%
9,227 $685,000
Q2 2019

Jul 24, 2019

SELL
$73.52 - $88.7 $882 - $1,064
-12 Reduced 0.14%
8,696 $739,000
Q1 2019

Apr 26, 2019

BUY
$63.56 - $88.17 $61,081 - $84,731
961 Added 12.4%
8,708 $749,000
Q4 2018

Feb 05, 2019

BUY
$58.5 - $69.94 $10,530 - $12,589
180 Added 2.38%
7,747 $493,000
Q3 2018

Nov 01, 2018

BUY
$61.75 - $74.23 $28,405 - $34,145
460 Added 6.47%
7,567 $523,000
Q1 2018

May 02, 2018

BUY
$83.06 - $100.98 $158,727 - $192,972
1,911 Added 36.78%
7,107 $592,000
Q4 2017

Feb 06, 2018

SELL
$93.56 - $116.6 $2.39 Million - $2.98 Million
-25,530 Reduced 83.09%
5,196 $492,000
Q3 2017

Nov 02, 2017

BUY
$109.15 - $138.27 $3.35 Million - $4.25 Million
30,726
30,726 $3.59 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $17.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.